605177.SH
Zhejiang East Asia Pharmaceutical Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 20.64
−0.43%Margins
Gross margin
20.8%
EBITDA margin
7.0%
EBIT margin
-11.0%
Net margin
-10.9%
FCF margin
-14.9%
-6.2%
Return on equity
-3.4%
Return on assets
-5.2%
Return on invested capital
0.31x
Asset turnover
-CNY 102.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026